Enzymatic and Chemical Synthesis for ADP‐Ribosylation Using NAD <sup>+</sup> as Building Blocks: New Concerns in Reaction Discovery and Design
Nicotinamide adenine dinucleotide (NAD<sup>+</sup>), as an endogenous donor for ADP-ribosylation, can modify DNA, RNA, and proteins, thereby participating in the regulation of the functions of these biomacromolecules. NAD<sup>+</sup> serves as a reactant in both enzymatic and chemical synthesis. By employing a well-designed reaction process, the synthetic route can be significantly streamlined, enabling the preparation of structurally complex bioactive molecules in a step-saving and highly effective manner. This article reviews the latest research progress in this field. In the field of enzymatic synthesis, a strategy based on the HPF1/PARP1 complex has been developed. Earlier study shows that the recombinant HPF1/PARP1 complex can ADP-ribosylate a variety of substrates in vitro. In the field of chemical synthesis, the focus is on ionic liquid-mediated ADP-ribosylation reactions with controllable α/β configurations of products. These reactions help prepare biologically active ADP-ribosylated (ADPr) peptides from NAD<sup>+</sup> and commercially available peptides. In addition, this article also outlines the applications of functional NAD<sup>+</sup> derivatives in enzyme activity analysis and inhibitor development and discusses the challenges faced in this field, such as bio-compatible reaction conditions, synthesis for precise structural control, and structure-activity relationships between stereochemistry and biological functions of more ADPr derivatives.
Authors
- Yanbo You
- Ling‐Jun Li (ORCID: https://orcid.org/0000-0003-0685-3189)
- Yiran Liu
Institutions
- Henan Normal University (CN)
Publication Details
- Journal
- ChemBioChem
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1002/cbic.202500731
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00